Paul Jeffrey, BS, MS, MBA, Commercialization Advisor, is a consultant and business advisor with over 40 years of pharmaceutical and biotech research, marketing, new product development, commercialization and business development experience. He is presently owner of PJ BioPharma Solutions and a Partner in BusStim, a virtual biotech accelerator. Clients include numerous biotech, pharma and technology companies. He also serves as an advisor and board member to several biotech entities. Prior to his present consulting work, Paul was with Pfizer for nearly 30 years where he rose to be VP, Early Commercial Development. He led many Pfizer multibillion dollar products to success including Zyrtec, Diflucan, Aricept, Chantix, Lipitor, and Eliquis. Paul was also responsible for many of Pfizer’s Primary Care Division business development deals including acquisitions, co-development and co-marketing collaborations as well as biotech licenses. He was a key player in the Pfizer/BMS collaboration deal that made Eliquis the world leading anticoagulant.